MENU
GNMSF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Genmab A/S (GNMSF) Ownership - Who owns Genmab A/S?
Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer... Show more
Profile
Industry
N/A
Address
Carl Jacobsens Vej 30
Phone
+45 70202728
Employees
2204
Web
https://www.genmab.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
13.52B
P/E Ratio
12.80
Total Cash
21.1B
Projected Growth
1.17
Total Debt
1.03B
Revenue
21.53B
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash/Share
342.60
Total Debt/Equity
N/A
Revenue/Share
48.46 USD as % of share price
Fundamentals
GNMSF
Capitalization
13.5B
P/E Ratio
12.80
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash
21.1B
Total Cash/Share
342.60
Total Debt
1.03B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
1.17
Revenue/Share (as % of the share price)
48.46%
Revenue
21.5B
ROE
N/A
Book Value
36.7B
P/B Ratio
2.54
Cash Flow
N/A
Earnings
122.21
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
66M
Current Ratio
5.25
Current Revenue Per Employee
2401566.00
Dividends Per Share - Security
N/A
EBITDA
9.7B
Float
N/A
Float - Current
N/A
Gross Income Margin
94.77
Revenue To Assets
19.34
Shares Held By Institutions
19B
Shares Outstanding - Current
61.6M
Total Liabilities
9.11B
Total Volume MTD
N/A
Value
N/A
Gain YTD
1.140
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Carl Jacobsens Vej 30
Phone
+45 70202728
Employees
2204
Web
https://www.genmab.com